Pancreatic cancer

Open trials

Title: CamStem111P- A Phase III Study of BBI-608 plus nab-Paclitaxel with Gemcitabine in Adult Patients with Metastatic Pancreatic Adenocarcinoma. Sponsor: Boston Biomedical – FDA IND number: 100,887 

Principal Investigator: Prof. Pierfrancesco Tassone

Contacts: Dr. Ivana Criniti (Tel: 0961-3694323- Fax: 0961-3647077) Email: ivana.criniti@unicz.it